Extracellular Matrix Dynamics in Hepatocarcinogenesis: a Comparative Proteomics Study of PDGFC Transgenic and Pten Null Mouse Models

We are reporting qualitative and quantitative changes of the extracellular matrix (ECM) and associated receptor proteomes, occurring during the transition from liver fibrosis and steatohepatitis to hepatocellular carcinoma (HCC). We compared two mouse models relevant to human HCC: PDGFC transgenic (Tg) and Pten null mice, models of disease progression from fibrosis and steatohepatitis to HCC. Using mass spectrometry, we identified in the liver of both models proteins for 26 collagen-encoding genes, providing the first evidence of expression at the protein level for 16 collagens. We also identified post-transcriptional protein variants for six collagens and lysine hydroxylation modifications for 14 collagens. Tumor-associated collagen proteomes were similar in both models with increased expression of collagens type IV, VI, VII, X, XIV, XV, XVI, and XVIII. Splice variants for Col4a2, Col6a2, Col6a3 were co-upregulated while only the short form of Col18a1 increased in the tumors. We also identified tumor specific increases of nidogen 1, decorin, perlecan, and of six laminin subunits. The changes in these non-collagenous ECM proteins were similar in both models with the exception of laminin β3, detected specifically in the Pten null tumors. Pdgfa and Pdgfc mRNA expression was increased in the Pten null liver, a possible mechanism for the similarity in ECM composition observed in the tumors of both models. In contrast and besides the strong up-regulation of integrin α5 protein observed in the liver tumors of both models, the expression of the six other integrins identified was specific to each model, with integrins α2b, α3, α6, and β1 up-regulated in Pten null tumors and integrins α8 and β5 up-regulated in the PDGFC Tg tumors. In conclusion, HCC–associated ECM proteins and ECM–integrin networks, common or specific to HCC subtypes, were identified, providing a unique foundation to using ECM composition for HCC classification, diagnosis, prevention, or treatment.

[1]  K. Hirata,et al.  Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule. , 2008, Experimental cell research.

[2]  R. Sherwin,et al.  Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. le Bail,et al.  Extracellular matrix composition and integrin expression in early hepatocarcinogenesis in human cirrhotic liver , 1997, The Journal of pathology.

[4]  I. Okayasu,et al.  Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: Comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas , 2005, Pathology international.

[5]  P. Trerotoli,et al.  Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins. , 2007, Hepatology.

[6]  R. Wells.  Cellular sources of extracellular matrix in hepatic fibrosis. , 2008, Clinics in liver disease.

[7]  J. Sanes,et al.  A simplified laminin nomenclature. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[8]  M. Ziol,et al.  Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis. , 2010, Gastroenterology.

[9]  R. Kalluri,et al.  Coordinate gene expression of the alpha3, alpha4, and alpha5 chains of collagen type IV. Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. , 1996, The Journal of biological chemistry.

[10]  Jyrki Heino,et al.  Cellular receptors of extracellular matrix molecules. , 2009, Current pharmaceutical design.

[11]  G. Gores,et al.  Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. , 2006, The Journal of clinical investigation.

[12]  T. Roskams.  Liver stem cells and their implication in hepatocellular and cholangiocarcinoma , 2006, Oncogene.

[13]  P. Bioulac-Sage,et al.  [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[14]  R. Kalluri,et al.  Coordinate Gene Expression of the α3, α4, and α5 Chains of Collagen Type IV , 1996, The Journal of Biological Chemistry.

[15]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[16]  K. Chien,et al.  Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511 , 2010, Nature Biotechnology.

[17]  D. Veitch,et al.  Type VII Collagen Is Required for Ras-Driven Human Epidermal Tumorigenesis , 2005, Science.

[18]  T. Mak,et al.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. , 2004, The Journal of clinical investigation.

[19]  Sopit Wongkham,et al.  Proteomic Studies of Cholangiocarcinoma and Hepatocellular Carcinoma Cell Secretomes , 2009, Journal of biomedicine & biotechnology.

[20]  Katja Schenke-Layland,et al.  Identification of the critical extracellular matrix proteins that promote human embryonic stem cell assembly. , 2009, Stem cells and development.

[21]  P. Trerotoli,et al.  Laminin‐5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins , 2007 .

[22]  Deepak Kolippakkam,et al.  Comprehensive and quantitative proteome profiling of the mouse liver and plasma , 2008, Hepatology.

[23]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[24]  Shelly C. Lu,et al.  Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A–deficient mice , 2007, Hepatology.

[25]  C. Sempoux,et al.  Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE‐induced murine model of chronic liver injury , 2009, Hepatology.

[26]  S. Baba,et al.  Thy1‐positive mesenchymal cells promote the maturation of CD49f‐positive hepatic progenitor cells in the mouse fetal liver , 2004, Hepatology.

[27]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[28]  Jung-Hwan Yoon,et al.  Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. , 2010, Cancer research.

[29]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[30]  J. Lillehaug,et al.  Structural and functional specificities of PDGF‐C and PDGF‐D, the novel members of the platelet‐derived growth factors family , 2005, The FEBS journal.

[31]  N. Fausto,et al.  Mouse Models of Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[32]  D. Schuppan,et al.  Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.

[33]  M. Yeh,et al.  Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[35]  T. Pihlajaniemi,et al.  Tumor hepatocytes and basement membrane–Producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers , 2001, Hepatology.

[36]  T. Pihlajaniemi,et al.  A Cryptic Frizzled Module in Cell Surface Collagen 18 Inhibits Wnt/β−Catenin Signaling , 2008, PloS one.

[37]  M. Birnbaum,et al.  Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2. , 2010, Gastroenterology.

[38]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[39]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.